Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP373864.RAkXvfAA9-e5vlvr7EHXc6Iw3inoXMppSNixjDFJlfZeQ130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP373864.RAkXvfAA9-e5vlvr7EHXc6Iw3inoXMppSNixjDFJlfZeQ130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP373864.RAkXvfAA9-e5vlvr7EHXc6Iw3inoXMppSNixjDFJlfZeQ130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP373864.RAkXvfAA9-e5vlvr7EHXc6Iw3inoXMppSNixjDFJlfZeQ130_provenance.
- NP373864.RAkXvfAA9-e5vlvr7EHXc6Iw3inoXMppSNixjDFJlfZeQ130_assertion description "[Furthermore, Hsp90 inhibitors 17-AAG [17-(allylamino)-17-demethoxygeldanamycin] and STA-9090 significantly reduced the growth of myeloid leukemia xenografts in vivo and effectively down-regulated the expression of WT1 and its downstream target proteins, c-Myc and Bcl-2.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP373864.RAkXvfAA9-e5vlvr7EHXc6Iw3inoXMppSNixjDFJlfZeQ130_provenance.
- NP373864.RAkXvfAA9-e5vlvr7EHXc6Iw3inoXMppSNixjDFJlfZeQ130_assertion evidence source_evidence_literature NP373864.RAkXvfAA9-e5vlvr7EHXc6Iw3inoXMppSNixjDFJlfZeQ130_provenance.
- NP373864.RAkXvfAA9-e5vlvr7EHXc6Iw3inoXMppSNixjDFJlfZeQ130_assertion SIO_000772 20651072 NP373864.RAkXvfAA9-e5vlvr7EHXc6Iw3inoXMppSNixjDFJlfZeQ130_provenance.
- NP373864.RAkXvfAA9-e5vlvr7EHXc6Iw3inoXMppSNixjDFJlfZeQ130_assertion wasDerivedFrom befree-20150227 NP373864.RAkXvfAA9-e5vlvr7EHXc6Iw3inoXMppSNixjDFJlfZeQ130_provenance.
- NP373864.RAkXvfAA9-e5vlvr7EHXc6Iw3inoXMppSNixjDFJlfZeQ130_assertion wasGeneratedBy ECO_0000203 NP373864.RAkXvfAA9-e5vlvr7EHXc6Iw3inoXMppSNixjDFJlfZeQ130_provenance.
- befree-20150227 importedOn "2015-02-27" NP373864.RAkXvfAA9-e5vlvr7EHXc6Iw3inoXMppSNixjDFJlfZeQ130_provenance.